lunes, 30 de marzo de 2026

FDA approves Rocket gene therapy for rare immune disorder Approval comes two years after rejection for manufacturing issues By Jason MastMarch 26, 2026 General Assignment Reporter

https://www.statnews.com/2026/03/26/rocket-pharma-kresladi-lad-1-fda-approval/

No hay comentarios:

Publicar un comentario